Frontiers in Oncology | Thoracic Oncology

Study Protocol

Published on 09 Mar 2023

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

in Thoracic Oncology

Marinda Meertens
M. Benthe Muntinghe-Wagenaar
Barend J. Sikkema
Marta Lopez-Yurda
Valesca P. Retèl
Marthe S. Paats
Rob Ter Heine
Ed Schuuring
Wim Timens
Daan J. Touw

Frontiers in Oncology

doi 10.3389/fonc.2023.1136221

10,529 views
10 citations

Review

Published on 09 Mar 2023

Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

in Thoracic Oncology

Yu-Chen Yang
Can-Jun Zhao
Zhao-Feng Jin
Jin Zheng
Li-Tian Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1120828

6,345 views
10 citations

Review

Published on 08 Mar 2023

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

in Thoracic Oncology

Remziye Zaim
W. Ken Redekop
Carin A. Uyl-de Groot

Frontiers in Oncology

doi 10.3389/fonc.2023.1027659

2,258 views
1 citation

Brief Research Report

Published on 08 Mar 2023

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

in Thoracic Oncology

Ziran Zhao
Yibo Gao
Fengwei Tan
Qi Xue
Shugeng Gao
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2023.1018288

3,173 views

Review

Published on 07 Mar 2023

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

in Thoracic Oncology

Qiuyuan Hu
Ke Li
Conghui Yang
Yue Wang
Rong Huang
Mingqiu Gu
Yuqiang Xiao
Yunchao Huang
Long Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1133164

7,424 views
26 citations

Original Research

Published on 07 Mar 2023

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

in Thoracic Oncology

Chengyu Chen
Qun Geng
Gesheng Song
Qian Zhang
Youruo Wang
Dongfeng Sun
Qingshi Zeng
Zhengjun Dai
Gongchao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1066360

2,831 views
12 citations

Original Research

Published on 06 Mar 2023

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis

in Thoracic Oncology

Qingwu Du
Wenting Liu
Ting Mei
Jingya Wang
Tingting Qin
Dingzhi Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1128443

5,221 views
12 citations

Original Research

Published on 03 Mar 2023

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer

in Thoracic Oncology

Ling Chen
Hong Jiang
Jun-jie Rao
Liu-sheng Wang
Wei Yan
Jian Ye
Jiang Lou

Frontiers in Oncology

doi 10.3389/fonc.2023.1146362

2,248 views
4 citations

Original Research

Published on 28 Feb 2023

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

in Thoracic Oncology

Po-Hsin Lee
Chun-Ju Chiang
Jeng-Sen Tseng
Zhe-Rong Zheng
Kun-Chieh Chen
Cheng-Hsiang Chu
Yen-Hsiang Huang
Kuo-Hsuan Hsu
Wen-Chung Lee
Tsung-Ying Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1096683

3,233 views
4 citations

Case Report

Published on 24 Feb 2023

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

in Thoracic Oncology

Konstantin Shilo
Peter J. Kneuertz
David Liebner
Wei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1096160

1,347 views
1 citation

Original Research

Published on 24 Feb 2023

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC

in Thoracic Oncology

Ping He
Jie Liu
Qingyuan Xu
Huaijun Ma
Beifang Niu
Gang Huang
Wei Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1089179

3,038 views

Original Research

Published on 23 Feb 2023

CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations

in Thoracic Oncology

Liping Kang
Jianliang Mai
Weiting Liang
Qihua Zou
Caiwen Huang
Yongbin Lin
Ying Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1094195

4,739 views
7 citations

Original Research

Published on 23 Feb 2023

Nomogram prediction model of postoperative pneumonia in patients with lung cancer: A retrospective cohort study

in Thoracic Oncology

Fan Jin
Wei Liu
Xi Qiao
Jingpu Shi
Rui Xin
Hui-Qun Jia

Frontiers in Oncology

doi 10.3389/fonc.2023.1114302

2,666 views
14 citations

Original Research

Published on 23 Feb 2023

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain

in Thoracic Oncology

Maria Torrente
Pedro A. Sousa
Gracinda R. Guerreiro
Fabio Franco
Roberto Hernández
Consuelo Parejo
Alexandre Sousa
José Luis Campo-Cañaveral
João Pimentão
Mariano Provencio

Frontiers in Oncology

doi 10.3389/fonc.2023.1074337

2,994 views
3 citations

Original Research

Published on 23 Feb 2023

Artificial-intelligence-based computed tomography histogram analysis predicting tumor invasiveness of lung adenocarcinomas manifesting as radiological part-solid nodules

in Thoracic Oncology

Jian Gao
Qingyi Qi
Hao Li
Zhenfan Wang
Zewen Sun
Sida Cheng
Jie Yu
Yaqi Zeng
Nan Hong
Dawei Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1096453

4,002 views
16 citations

Original Research

Published on 22 Feb 2023

Multivariate analysis of prognostic factors in patients with lung cancer

in Thoracic Oncology

Changjiang Liu
Minting Ma
Xuetao Zhou
Zefeng Zhang
Yang Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1022862

3,385 views
2 citations

Review

Published on 22 Feb 2023

Multiple primary lung cancer: Updates of clinical management and genomic features

in Thoracic Oncology

He Tian
Guangyu Bai
Zhenlin Yang
Ping Chen
Jiachen Xu
Tiejun Liu
Tao Fan
Bingning Wang
Chu Xiao
Chunxiang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1034752

11,156 views
24 citations

Case Report

Published on 20 Feb 2023

Intrathymic growing bronchogenic cyst mimicking thymoma: A case report

in Thoracic Oncology

Madalina Grigoroiu
Sarah Paisley
Emmanuel Brian
Delphine Natali

Frontiers in Oncology

doi 10.3389/fonc.2023.1121321

2,638 views
2 citations

Editorial

Published on 16 Feb 2023

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms

in Thoracic Oncology

Maria Giovanna Mastromarino
Vittorio Aprile
Marco Lucchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1158416

1,795 views
4 citations

Editorial

Published on 16 Feb 2023

Editorial: Local ablative therapies for the management of lung cancer

in Thoracic Oncology

Zhigang Wei
Roberto Iezzi
Xin Ye

Frontiers in Oncology

doi 10.3389/fonc.2023.1160932

1,573 views
2 citations

Case Report

Published on 16 Feb 2023

Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature

in Thoracic Oncology

Yuetian Pan
Hongshang Cui
Yongbin Song

Frontiers in Oncology

doi 10.3389/fonc.2023.1109274

3,999 views
9 citations

Case Report

Published on 16 Feb 2023

Nonfunctional ectopic adrenocortical carcinoma in the lung: A case report and literature review

in Thoracic Oncology

Limin Nie
Shuyun Wang
Zongfeng Feng
Yuping Sun
Zhen Wang
Qi Dang
Aiqin Gao
Yajuan Lv

Frontiers in Oncology

doi 10.3389/fonc.2023.1100207

2,075 views
4 citations

Hypothesis and Theory

Published on 14 Feb 2023

Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab

in Thoracic Oncology

Butuo Li
Linlin Yang
Chao Jiang
Yueyuan Yao
Haoqian Li
Shuping Cheng
Bing Zou
Bingjie Fan
Linlin Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1052147

2,998 views
9 citations

Original Research

Published on 13 Feb 2023

Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy

in Thoracic Oncology

Michael R. Sayer
Isa Mambetsariev
Kun-Han Lu
Chi Wah Wong
Ashley Duche
Richard Beuttler
Jeremy Fricke
Rebecca Pharoan
Leonidas Arvanitis
Zahra Eftekhari

Frontiers in Oncology

doi 10.3389/fonc.2023.1064169

5,176 views
12 citations

1,911 articles

articles

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC

CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations

Nomogram prediction model of postoperative pneumonia in patients with lung cancer: A retrospective cohort study

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain

Artificial-intelligence-based computed tomography histogram analysis predicting tumor invasiveness of lung adenocarcinomas manifesting as radiological part-solid nodules

Multivariate analysis of prognostic factors in patients with lung cancer

Multiple primary lung cancer: Updates of clinical management and genomic features

Intrathymic growing bronchogenic cyst mimicking thymoma: A case report

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms

Editorial: Local ablative therapies for the management of lung cancer

Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature

Nonfunctional ectopic adrenocortical carcinoma in the lung: A case report and literature review

Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab

Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy